Review
Published on 25 Apr 2025
Expanding horizons of cancer immunotherapy: hopes and hurdles
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1511560
- 157 views
Type at least 3 characters
1,409 articles
Original Research
Accepted on 23 Apr 2025
MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1595485
Original Research
Accepted on 23 Apr 2025
Integrated single-cell and transcriptome sequencing data reveal the value of IL1RAP in gastric cancer microenvironment and prognosis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1584619
- 120 views
Original Research
Accepted on 21 Apr 2025
A Novel Tc17 Population Recruited by Tumor Cells Promotes Tumor Progression in Gastric Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1592328
Review
Accepted on 17 Apr 2025
Advances in Neoantigen-based Immunother apy for Head and Neck Squamous Cell Car cinoma (HNSCC): A Compr ehensive Review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1593048
- 123 views
Case Report
Accepted on 17 Apr 2025
Acral vasculitis induced by Immune Checkpoint Inhibitor : case series and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1537825
- 133 views
Case Report
Published on 16 Apr 2025
Case Report: A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1517391
- 294 views
Original Research
Accepted on 14 Apr 2025
Combined Stereotactic Radiation Therapy and Immunotherapy for Metastatic Uveal Melanoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1567504
- 144 views
Original Research
Accepted on 14 Apr 2025
Neutrophil/lymphocyte ratio (NLR): a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1557652
- 125 views
Original Research
Accepted on 10 Apr 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1579214
- 113 views
Mini Review
Published on 09 Apr 2025
Activation-induced cytidine deaminase in tertiary lymphoid structures: dual roles and implications in cancer prognosis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1555491
- 297 views
Mini Review
Published on 09 Apr 2025
Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1566202
- 339 views
Mini Review
Published on 09 Apr 2025
Single-cell RNA sequencing in diffuse large B-cell lymphoma: tumor heterogeneity, microenvironment, resistance, and prognostic markers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1583250
- 385 views
Brief Research Report
Published on 08 Apr 2025
Amyloid precursor-like protein 2 expression in macrophages: differentiation and M1/M2 macrophage dynamics
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1570955
- 549 views
Editorial
Accepted on 07 Apr 2025
Editorial: The Tumor Microenvironment and Immunotherapy for Head and Neck Tumors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1606787
Editorial
Published on 07 Apr 2025
Editorial: Mitochondria in the regulation of anti-tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1596146
- 402 views